Newcleo Raises $247M, Goes Public via SPAC to Accelerate Nuclear Reactor Commercialization

  • Newcleo completed its business combination with NewHold Investment Corp III, raising $247 million in gross proceeds.
  • The company will begin trading on the Nasdaq under the ticker symbol 'NWCL' on September 22, 2026.
  • The transaction valued newcleo at a pre-money equity value of approximately $2.4 billion.
  • Up to an additional $75 million may become available under a forward purchase agreement.
  • Newcleo has raised close to $20 million since the business combination announcement, bringing total funds raised to over $1 billion.

Newcleo's public listing via SPAC marks a significant milestone in the advanced modular reactor (AMR) space, providing the company with substantial capital to accelerate its lead-cooled fast reactor and MOX nuclear fuel production towards commercialization. The transaction underscores the growing interest in nuclear innovation as a solution for clean, sustainable energy. With a strong capital foundation and an experienced board of directors, newcleo is well-positioned to navigate the complexities of the nuclear industry and capitalize on the increasing demand for low-carbon power solutions.

Regulatory Headwinds
The pace at which newcleo advances regulatory and licensing interactions with U.S. and French nuclear safety regulators will determine its commercialization timeline.
Execution Risk
How newcleo deploys the additional capital to support its global growth, complete its 10MWth non-nuclear demonstrator in Italy, and pursue commercial opportunities will be critical to its success.
Market Dynamics
Whether newcleo can sustain its momentum in the growing global nuclear industry and serve the increasing need for reliable, low-carbon power.